NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
NCI offers small grants for cancer research projects, allowing for quick and resource-efficient studies in various project types.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: February 24, 2025 | June 20, 2025 | October 17, 2025 (New/Renewal/Resubmission/Revision) | May 7, 2025 | September 7, 2025 | January 7, 2026 (AIDS-related)
Funding Amounts: Up to $50,000 direct costs per year, for a maximum of 2 years (total up to $100,000 direct costs).
Summary: Supports small, well-defined cancer research projects that can be completed in a short period with limited resources, including pilot studies, data analysis, and technology/methodology development.
Key Information: Clinical trials are optional; foreign organizations are eligible; updated March 2025 to align with agency priorities—review full NOFO before applying.
Description
This opportunity supports small, discrete, well-defined research projects in any area of cancer research using the NIH R03 small grant mechanism. The program is designed for projects that can be realistically completed within two years and require limited funding. Eligible project types include pilot or feasibility studies, secondary analysis of existing data, small self-contained research projects, development of research methodology, and development of new research technology.
Projects may involve basic, translational, clinical, or population research relevant to the mission of the National Cancer Institute (NCI). Examples include studies in cancer biology, control, diagnosis, disparities, prevention, and treatment. Both clinical trial and non-clinical trial applications are accepted.
